carbamates has been researched along with Neurodegenerative Diseases in 6 studies
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Podbielska, M | 1 |
| Das, A | 1 |
| Smith, AW | 1 |
| Chauhan, A | 1 |
| Ray, SK | 1 |
| Inoue, J | 1 |
| Azuma, M | 1 |
| Nozaki, K | 1 |
| Hogan, EL | 1 |
| Banik, NL | 1 |
| Ballatore, C | 2 |
| Zhang, B | 1 |
| Trojanowski, JQ | 2 |
| Lee, VM | 2 |
| Smith, AB | 2 |
| Linton, SD | 1 |
| Aja, T | 1 |
| Allegrini, PR | 1 |
| Deckwerth, TL | 1 |
| Diaz, JL | 1 |
| Hengerer, B | 1 |
| Herrmann, J | 1 |
| Jahangiri, KG | 1 |
| Kallen, J | 1 |
| Karanewsky, DS | 1 |
| Meduna, SP | 1 |
| Nalley, K | 1 |
| Robinson, ED | 1 |
| Roggo, S | 1 |
| Rovelli, G | 1 |
| Sauter, A | 1 |
| Sayers, RO | 1 |
| Schmitz, A | 1 |
| Smidt, R | 1 |
| Ternansky, RJ | 1 |
| Tomaselli, KJ | 1 |
| Ullman, BR | 1 |
| Wiessner, C | 1 |
| Wu, JC | 1 |
| Mora, G | 1 |
| Tapia, R | 1 |
| Van der Schyf, CJ | 1 |
| Gal, S | 1 |
| Geldenhuys, WJ | 1 |
| Youdim, MB | 1 |
| Hyde, E | 1 |
| Deiches, RF | 1 |
| Huryn, D | 1 |
1 review available for carbamates and Neurodegenerative Diseases
| Article | Year |
|---|---|
Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases.
Topics: Acetylcholine; Adenosine A2 Receptor Antagonists; Animals; Apoptosis; Calcium; Calcium Channel Block | 2006 |
5 other studies available for carbamates and Neurodegenerative Diseases
| Article | Year |
|---|---|
Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation.
Topics: Animals; Calpain; Carbamates; Cell Survival; Cysteine Proteinase Inhibitors; Dipeptides; Enzyme Acti | 2016 |
In situ blood-brain barrier permeability of a C-10 paclitaxel carbamate.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Carbam | 2008 |
Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke.
Topics: Apoptosis; Carbamates; Caspase Inhibitors; Cell Line; Dipeptides; Humans; Inhibitory Concentration 5 | 2004 |
Effects of retigabine on the neurodegeneration and extracellular glutamate changes induced by 4-aminopyridine in rat hippocampus in vivo.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Carbamates; Drug Interactions; Electroencephalography; Ex | 2005 |
Paclitaxel C-10 carbamates: potential candidates for the treatment of neurodegenerative tauopathies.
Topics: Animals; Blood-Brain Barrier; Brain; Carbamates; Chemistry, Pharmaceutical; Drug Design; Humans; Mic | 2007 |